variabl
number
tandem
repeat
vntr
conjug
tumorassoci
carbohydr
antigen
taca
shown
break
selftoler
human
transgen
mice
therefor
hypothes
vntr
tacaconjug
success
formul
liposomebas
anticanc
vaccin
immunogen
vaccin
augment
incorpor
surfac
display
lrhamnos
rha
epitop
onto
liposom
take
advantag
natur
antibodydepend
antigen
uptak
mechan
valid
hypothesi
synthes
acid
glycopeptid
contain
galnacothr
tn
taca
spp
conjug
function
tolllik
receptor
ligand
tlrl
lrhacholesterol
conjug
prepar
use
tetraethylen
glycol
teg
linker
liposomebas
anticanc
vaccin
formul
extrus
method
use
conjug
rhategcholesterol
dppc
total
lipid
concentr
mm
stabil
homogen
size
character
liposom
evalu
sem
dl
measur
formul
liposom
demonstr
posit
bind
antirha
mous
antihuman
antibodi
group
femal
balbc
mice
immun
boost
rhamnoseficol
rhaficol
conjug
formul
alum
adjuv
gener
appropri
concentr
antirha
antibodi
mice
antirha
antibodi
titer
higher
group
mice
immun
rhaficol
conjug
nonimmun
control
group
mice
immun
liposom
vaccin
formul
either
without
surfac
display
rha
epitop
sera
collect
group
mice
initi
immun
rhaficol
later
vaccin
rhadisplay
liposom
show
increas
antitn
antibodi
titer
comparison
group
mice
receiv
rhaficol
tcell
balbc
mice
prime
peptid
demonstr
increas
prolifer
rhaliposom
vaccin
presenc
antibodi
isol
rhaficol
immun
mice
compar
nonimmun
mice
support
correspond
author
stevesucheck
utoledoedu
kwall
utnetutoledoedu
associ
content
support
inform
experiment
comparison
antirha
antibodi
gener
rhaficol
versu
rhaova
tcell
prolifer
studi
test
cell
respons
balbc
mice
glycopeptid
copi
h
c
h
gcosi
nmr
spectra
hrm
data
compound
malditof
spectra
esim
dl
measur
graph
batch
liposom
buffer
figur
antirha
antibodi
isotyp
titer
tcell
prolifer
balbc
mice
peptid
presenc
absenc
dendrit
cell
materi
avail
free
charg
via
internet
propos
effect
antigen
present
antibodi
vaccin
mice
serum
recogn
human
leukemia
cell
vaccin
use
separ
rhamnos
antigen
epitop
compon
vaccin
easili
target
differ
antigen
epitop
chang
peptid
without
chang
compon
tumorassoci
carbohydr
antigen
taca
found
use
cancer
immunotherapi
marker
cancer
detect
diseas
progress
overexpress
aberr
structur
distribut
taca
tumor
cell
rel
normal
cell
make
potenti
target
anticanc
vaccin
numer
taca
identifi
glycoprotein
obtain
cancer
cell
epitheli
origin
antigen
includ
thomsenfriedenreich
tf
tn
stn
well
antigen
recent
find
made
finn
cowork
report
variabl
number
tandem
repeat
vntr
contain
taca
potent
break
self
toler
transgen
mice
unglycosyl
vntr
author
believ
glycopeptid
foreign
like
epitop
comparison
unglycosyl
self
like
vaccin
tacacontain
success
gener
glycopeptid
specif
antibodi
boost
previous
suppress
specif
tcell
respons
identifi
popul
dendrit
cell
dc
display
vntr
bear
gs
galnacot
epitop
mhc
classii
molecul
consid
differ
way
glycopeptid
could
formul
anticanc
vaccin
improv
immunogen
believ
interest
approach
would
incorpor
xenoantigen
onto
target
antigen
xenoantigen
would
complex
natur
occur
cognat
antibodi
would
facilit
uptak
target
antigen
antigen
present
cell
apc
past
studi
focus
instal
epitop
vaccin
construct
boost
immun
respons
promis
result
sinc
human
serum
abund
antibodi
howev
recent
studi
bovin
gildersleev
human
serum
reveal
even
abund
human
natur
anticarbohydr
antibodi
present
xenoantigen
lrhamnos
rha
antirha
antibodi
gener
nontransgen
mice
contrast
antibodi
paper
explor
rha
eptiop
noncovalentlylink
ligand
display
surfac
liposom
vaccin
enhanc
immun
respons
tumorassoci
glycopeptid
fragment
mice
produc
antirha
antibodi
import
strategi
develop
success
anticanc
vaccin
effici
deliveri
antigen
apc
liposom
effect
deliveri
viral
bacteri
tumor
antigen
apc
advantag
protect
peptidebas
antigen
proteolysi
vivo
liposom
also
gener
multival
vaccin
promot
numer
antigenantibodi
interact
facilit
opson
vaccin
addit
mechan
may
also
involv
rha
epitop
interact
endogen
bcell
receptor
bcr
uptak
present
antigen
bcell
vaccin
immunogen
also
improv
introduct
adjuv
tolllik
receptor
ligand
tlrl
exampl
potent
adjuv
activ
therefor
incorpor
prototyp
ligand
pam
cy
vaccin
synthesi
serv
dual
role
adjuv
lipid
anchor
liposom
envis
liposom
capabl
display
rha
epitop
latter
design
bind
endogen
antirha
antibodi
human
serum
result
igvaccin
complex
would
taken
apc
figur
fine
chemic
lrhamnos
cholesterol
ptoluen
sulfonyl
chlorid
copper
sulfat
etc
anhydr
solvent
anhydr
methanol
purchas
acro
organ
dppc
obtain
avanti
polar
lipid
inc
alabast
al
boron
trifluorid
ether
aldrich
chemic
use
without
purif
solvent
obtain
fisher
use
receiv
except
dichloromethan
dri
distil
follow
standard
procedur
silica
mesh
flash
column
chromatographi
obtain
sorbent
technolog
thinlay
chromatographi
tlc
precoat
plate
emd
tlc
silica
gel
f
visual
uv
light
char
h
meoh
flash
column
chromatographi
perform
silica
gel
mesh
use
solvent
receiv
h
nmr
record
either
varian
vxr
mhz
inova
mhz
spectromet
cdcl
cd
od
use
residu
chcl
chd
oh
intern
refer
respect
c
nmr
record
varian
vxr
mhz
inova
mhz
cdcl
use
triplet
center
cd
od
use
septet
center
intern
refer
high
resolut
mass
spectrometri
hrm
perform
tof
mass
spectromet
peptid
synthes
omega
synthes
advanc
chemtech
louisvil
ky
tri
methyl
amin
tbta
preload
fmoclalawang
resin
fmoclamino
acid
procur
anaspec
san
jose
ca
ficollr
imjectr
alum
purchas
sigma
thermo
scientif
respect
fitc
goat
antimous
iggigm
purifi
mous
antihuman
antihuman
obtain
bdbioscienc
san
jose
ca
scan
electron
microscop
imag
done
jeol
field
scan
electron
microscop
dynam
light
scatter
measur
done
dynapro
titan
temperatur
control
microsampl
wyatt
technolog
corpor
fluoresc
microscopi
done
nikon
tiu
microscop
secondari
antibodi
obtain
jackson
immunoresearch
laboratori
west
grove
pa
femal
balbc
mice
week
old
obtain
jackson
laboratori
bar
harbor
human
leukemia
cell
purchas
american
type
cultur
collect
manassa
va
solut
rhamnopyranos
g
mmol
ch
cl
ml
ad
n
mmol
ch
cl
mixtur
cool
bf
oet
ml
mmol
ad
dropwis
reaction
mixtur
result
solut
stir
ambient
temperatur
n
atmospher
reaction
monitor
tlc
etoac
hexan
appear
complet
h
reaction
mixtur
dilut
ch
cl
ml
wash
satur
nahco
ml
water
ml
brine
ml
organ
layer
dri
anhydr
na
excess
solvent
evapor
reduc
pressur
residu
purifi
silica
gel
flash
column
chromatographi
use
etoac
hexan
solvent
afford
light
yellow
solid
g
solut
g
mmol
meoh
ml
ad
metal
sodium
g
result
solut
stir
ambient
temperatur
n
atmospher
reaction
monitor
tlc
meoh
ch
cl
appear
complet
h
solut
neutral
amberlit
h
exchang
resin
excess
solvent
evapor
reduc
pressur
residu
purifi
silica
gel
flash
column
chromatographi
use
meoh
ch
cl
solvent
afford
yellowish
white
solid
g
pam
fmocci
tertiari
butyl
ester
g
mmol
dissolv
minimum
volum
neat
tfa
ml
stir
ambient
temperatur
n
atmospher
tlc
etoac
hexan
indic
complet
reaction
h
reaction
mixtur
evapor
dryness
vacuum
residu
dissolv
ch
cl
ml
pybop
g
mmol
hobt
mg
mmol
dipea
mmol
mol
siev
bead
ad
sequenti
mixtur
stir
minut
room
temperatur
follow
addit
propargyl
amin
mmol
stir
ambient
temperatur
n
atmospher
reaction
monitor
tlc
etoac
hexan
appear
complet
h
reaction
mixtur
filter
wash
phosphat
buffer
ml
extract
ch
cl
ml
organ
layer
dri
anhydr
na
concentr
residu
purifi
silica
gel
flash
column
chromatographi
use
etoachexan
solvent
afford
white
solid
mg
compound
mg
mmol
dissolv
mixtur
ch
cnch
cl
et
nh
ml
stir
ambient
temperatur
n
atmospher
tlc
etoac
hexan
indic
complet
deprotect
fmoc
group
h
reaction
mixtur
evapor
dryness
vacuum
palmit
acid
mg
mmol
pybop
mg
mmol
hobt
mg
mmol
dissolv
ch
cl
ml
follow
addit
dipea
mmol
mixtur
stir
minut
ad
residu
fmoc
deprotect
product
compound
contain
mol
siev
bead
reaction
mixtur
stir
ambient
temperatur
n
atmospher
reaction
monitor
tlc
etoac
hexan
appear
complet
h
reaction
mixtur
dilut
ch
cl
ml
filter
evapor
dryness
residu
purifi
silica
gel
flash
column
chromatographi
use
etoac
hexan
solvent
afford
pale
yellow
solid
mg
glycopeptid
azid
synthes
fmoc
strategi
omega
synthes
advanc
chemtech
louisvil
ky
use
solid
phase
chemistri
peptid
synthesi
perform
coupl
amino
acid
ester
hobt
use
dic
coupl
agent
excess
n
fmoc
amino
acid
ester
hobt
nmp
use
synthesi
ratio
amino
acid
dic
use
coupl
reaction
deprotect
n
fmoc
group
accomplish
treatment
piperidin
dimethylformamid
twice
first
minut
second
time
minut
synthesi
complet
peptid
cleav
solid
support
deprotect
use
modifi
reagent
k
cocktail
consist
tfa
thioanisol
ethanedithiol
water
phenol
ml
cleavag
cocktail
ad
dri
peptideresin
ml
glass
vial
blanket
nitrogen
cleavag
carri
hr
gentl
magnet
stir
end
cleavag
time
cocktail
mixtur
filter
quicksnap
column
filtrat
collect
ml
icecold
butan
ether
peptid
allow
precipit
hour
centrifug
wash
twice
icecold
methyltbutyl
ether
precipit
dissolv
acetonitril
lyophil
complet
dri
powder
qualiti
peptid
analyz
analyt
revers
phase
hplc
malditof
matrix
assist
laser
desorpt
ioniz
timeofflight
mass
spectromet
model
appli
biosystem
hrmaldim
mh
mz
calcd
c
h
n
found
compound
mg
dissolv
ml
dri
methanol
freshli
prepar
sodium
methoxid
ad
reaction
mixtur
stir
ambient
temperatur
n
atmospher
h
reaction
mixtur
neutral
solid
carbon
dioxid
reaction
mixtur
concentr
purifi
biogel
fine
size
exclus
chromatographi
use
deioniz
water
solvent
lyophil
elut
afford
white
powder
mg
cuso
tbta
mg
dissolv
h
thf
ml
naascorb
mg
ad
stir
minut
size
determin
liposom
done
scan
electron
microscop
sem
imag
dynam
light
scatter
dl
measur
sem
character
liposom
sampl
dilut
time
hepe
buffer
ph
freez
dri
copper
stud
fit
carbon
conduct
tape
imag
record
acceler
voltag
kv
dl
measur
done
dilut
liposom
sampl
time
hepe
buffer
ph
one
million
liposom
batch
zl
phosphat
buffer
salin
pb
ad
separ
ml
eppendorf
tube
follow
zl
primari
antibodi
solut
prepar
dilut
deioniz
water
contain
zgml
antibodi
either
control
igg
isol
serum
nonimmun
mice
antirha
igg
isol
serum
rhaovalbumin
immun
mice
mous
antihuman
monoclon
antibodi
antihuman
incub
ice
min
ml
tween
ad
tube
vortex
liposom
centrifug
rpm
eppendorf
centrifug
min
supernat
care
discard
wash
centrifug
step
repeat
time
total
wash
liposom
resuspend
zl
tween
zl
dilut
fitc
goat
antimous
iggigm
secondari
antibodi
ad
zgml
tube
mix
cover
aluminum
foil
protect
light
incub
ice
min
wash
time
tween
centrifug
supernat
remov
pellet
resuspend
ml
tween
zl
resuspend
solut
put
glass
slide
imag
fluoresc
microscop
solut
g
mmol
ch
cl
ml
ad
g
mmol
bf
oet
ml
mmol
result
solut
stir
ambient
temperatur
n
atmospher
reaction
monitor
tlc
appear
complet
h
reaction
mixtur
dilut
ch
cl
ml
wash
water
ml
satur
nahco
ml
brine
ml
organ
layer
dri
anhydr
na
excess
solvent
remov
reduc
pressur
crude
materi
purifi
silica
gel
flash
column
chromatographi
cm
elut
etoachexan
afford
colorless
solid
g
solut
g
mmol
meoh
ml
ad
metal
na
g
result
solut
stir
ambient
temperatur
n
atmospher
reaction
monitor
tlc
appear
complet
h
excess
solvent
remov
reduc
pressur
crude
materi
purifi
silica
gel
flash
column
chromatographi
cm
elut
meohch
cl
yield
colorless
solid
g
solut
g
mmol
meoh
ml
ad
activ
pdcharcoal
g
result
solut
stir
ambient
temperatur
h
atmospher
reaction
monitor
tlc
appear
complet
h
reaction
mixtur
dilut
meoh
ml
filter
celit
concentr
reduc
pressur
yield
colorless
gel
g
quantit
use
without
purif
subsequ
reaction
esim
h
mz
cacld
c
h
found
ficol
g
mmol
dissolv
acet
buffer
ml
ph
naio
g
mmol
ad
reaction
mixtur
stir
ambient
temperatur
h
dark
excess
naio
remov
dialysi
acet
buffer
ph
dialysi
tube
molecular
weight
cutoff
valu
da
six
seven
chang
buffer
oxid
ficol
transfer
round
bottom
flask
excess
solvent
evapor
dryness
reduc
pressur
residu
dissolv
borat
buffer
ml
ph
follow
addit
g
mmol
stir
ambient
temperatur
h
reaction
mixtur
ad
nabh
cn
g
mmol
result
solut
incub
overnight
mixtur
dialyz
dialysi
tube
molecular
weight
cutoff
valu
da
six
seven
chang
buffer
afford
epitop
ratio
calcul
rha
ficol
hydrolysi
follow
derivat
diethylamino
ethyl
benzamid
deaeab
comparison
uvhplc
peak
area
standard
curv
obtain
deaeab
deriv
method
describ
dalpathado
cowork
briefli
standard
curv
gener
reflux
compound
g
mmol
n
hcl
h
reaction
mixtur
evapor
dryness
residu
dissolv
tetrahydrofuran
ml
deaeab
g
mmol
et
n
ml
mmol
ad
result
solut
reflux
h
reaction
mixtur
evapor
dryness
residu
dissolv
meoh
ml
follow
addit
nab
oac
h
result
solut
reflux
h
solut
evapor
dryness
residu
dissolv
meoh
ml
filter
syring
filter
serial
dilut
stock
solut
prepar
compon
separ
revers
phase
hplc
use
column
water
contain
tfa
acnh
b
use
mobil
phase
use
linear
gradient
b
min
flow
rate
mlmin
absorb
record
nm
standard
curv
gener
plot
uvhplc
peak
area
concentr
mmol
deaeab
deriv
one
femal
balbc
mous
week
old
jackson
laboratori
prime
day
boost
three
time
day
subcutan
inject
equivolum
emuls
conjug
prepar
phosphat
buffer
salinepb
sigma
adjuv
system
sa
peptid
per
mous
inject
rhaficol
rhaova
immun
mice
support
inform
bled
day
sera
pool
igg
fraction
pool
prepar
precipit
satur
ammonium
sulfat
mixtur
incub
overnight
centrifug
g
minut
resuspend
ml
water
antibodi
solut
concentr
buffer
chang
twice
pb
use
ultrafre
centrifug
filter
devic
millipor
billerica
molecular
cut
absorb
antibodi
solut
record
nm
calcul
concentr
antirha
antibodi
solut
gener
isol
rhaficol
rhaova
immun
mice
dilut
mgml
day
mous
sacrif
spleen
remov
place
ml
freshli
prepar
spleen
cell
cultur
medium
dmem
fetal
calf
serum
singl
cell
suspens
prepar
use
modifi
steril
glass
homogen
cell
wash
three
time
cultur
medium
brought
cellsml
spleen
cell
suspens
ad
well
plate
cell
per
well
dendrit
cell
dc
suspens
cultur
bone
marrow
balbc
mous
support
inform
puls
antigen
incub
rhadisplay
liposom
antigen
concentr
h
togeth
antirha
antibodi
gener
either
rhaficol
rhaova
immun
mice
sera
per
well
control
antibodi
isol
nonimmun
mice
serum
puls
dc
ad
well
contain
spleen
cell
dc
per
well
plate
incub
day
day
cell
puls
h
thymidin
per
well
incub
overnight
cell
harvest
glassfib
filter
incorpor
determin
measur
top
count
scintil
counter
packard
downer
grove
il
femal
balbc
mice
use
studi
divid
four
group
contain
mice
group
serv
control
group
immun
group
inject
subcutan
day
equivolum
emuls
rhaficol
conjug
alum
rhaficol
per
mous
mice
boost
subcutan
inject
rhaficollalum
day
rhaficol
per
mous
boost
mice
group
bled
day
collect
sera
test
antirha
antibodi
well
plate
immulon
hbx
coat
rhabsa
conjug
pb
incub
overnight
plate
wash
time
pb
contain
block
achiev
incub
plate
h
room
temperatur
bsa
pb
plate
wash
time
incub
h
serum
dilut
pb
unbound
antibodi
serum
remov
wash
plate
incub
h
room
temperatur
horseradish
peroxidas
hrp
goat
antimous
igg
igm
jackson
immunoresearch
laboratori
dilut
time
pbsbsa
plate
wash
tmb
one
compon
hrp
microwel
substrat
bio
fx
owe
mill
md
ad
allow
react
min
absorb
record
nm
plot
log
dilut
vaccin
perform
day
two
separ
liposom
formul
prepar
dppc
cholesterol
pam
nmol
pam
liposom
dppc
cholesterol
rhategcholesterol
pam
nmol
pam
rha
liposom
total
lipid
concentr
mmol
group
vaccin
subcutan
inject
pam
liposom
nmol
peptid
per
mous
group
vaccin
subcutan
inject
pam
rha
liposom
nmol
peptid
per
mous
mice
boost
day
either
pam
liposom
group
nmol
peptid
per
mous
pam
rha
liposom
group
mice
bled
day
sera
collect
test
antitn
antibodi
well
plate
immulon
hbx
coat
conjug
pb
incub
overnight
elisa
continu
describ
well
plate
immulon
hbx
coat
tnbsa
conjug
pb
incub
overnight
elisa
continu
describ
well
plate
immulon
hbx
coat
conjug
pb
incub
overnight
plate
wash
time
pb
contain
block
achiev
incub
plate
h
room
temperatur
bsa
pb
plate
wash
time
incub
h
serum
dilut
pb
unbound
antibodi
serum
remov
wash
plate
incub
overnight
subclass
specif
igm
rabbit
antimous
antibodi
zyme
laboratori
mous
monoabid
kit
plate
wash
incub
hrpgoat
antirabbit
igg
hl
h
room
temperatur
plate
wash
abt
substrat
buffer
dilut
time
ad
allow
react
min
absorb
record
nm
compar
antibodi
subclass
group
well
plate
immulon
hbx
coat
conjug
pb
incub
overnight
plate
wash
time
pb
contain
block
achiev
incub
plate
h
room
temperatur
bsa
pb
plate
wash
time
incub
h
serum
dilut
pb
without
prior
mix
vari
concentr
free
compound
pb
unbound
antibodi
serum
remov
wash
plate
incub
h
room
temperatur
horseradish
peroxidas
hrp
goat
antimous
igg
igm
secondari
antibodi
dilut
time
pbsbsa
plate
wash
tmb
compon
hrp
microwel
substrat
ad
allow
react
min
absorb
record
nm
plot
log
tn
concentr
cell
american
type
cultur
collect
manassa
va
cultur
rpmi
fetal
calf
serum
fc
cell
stain
purifi
mous
antihuman
antibodi
nonimmun
balbc
mice
serum
dilut
group
mice
serum
dilut
cell
stain
fitcconjug
goat
antimous
igg
igm
fluoresc
quantifi
bd
fac
calibur
valid
hypothesi
first
synthes
lrhacholesterol
conjug
use
tetraethylen
glycol
teg
linker
report
facilit
format
smallsiz
homogen
liposom
allow
good
bind
interact
head
group
scheme
cholesterol
tetraethylen
glycol
glycosyl
peracetyl
rhamnos
presenc
boron
trifluorid
ether
afford
peracetyl
rhamnosetegcholesterol
deacetyl
zemplen
condit
gener
rhategcholesterol
liposom
formul
cholesterol
fragment
anchor
rha
epitop
surfac
liposom
therebi
facilit
antirha
antibodi
bind
next
target
synthes
function
tolllik
receptor
ligand
tlrl
serv
purpos
immunoadjuv
vaccin
candid
also
anchor
conjug
surfac
liposom
focus
attent
toward
synthesi
conjug
form
lipopeptid
r
npalmitoyl
r
cystein
pam
cy
identifi
agonist
success
use
past
immonoadjuv
design
three
compon
vaccin
plan
incorpor
alkyn
function
amid
linkag
ctermin
pam
cy
conjug
azid
moieti
construct
simpl
coppercatalyz
click
reaction
synthes
conjugat
pam
cy
alkyn
scheme
first
tertbutyl
protect
opalmitoyl
fmoc
lcystin
tertbutyl
ester
cleav
brief
treatment
trifluoroacet
acid
tfa
free
acid
coupl
propargyl
amin
presenc
hexafluorophosph
pybop
hobt
n
ndiisopropylethylamin
dipea
yield
step
final
fmoc
group
compound
remov
treatment
mixtur
acetonitriledichloromethanediethyl
amin
follow
subsequ
palmitoyl
coupl
palmit
acid
pybop
hobt
dipea
afford
target
alkyn
function
pam
cy
amid
deriv
step
synthesi
construct
target
acid
tandem
repeat
includ
gs
galnacot
epitop
identifi
finn
et
al
plan
instal
termin
azido
group
glycopeptid
would
make
click
conjug
pam
cy
alkyn
feasibl
glycopeptid
azid
synthes
fmoc
strategi
omega
synthes
advanc
chemtech
louisvil
ky
start
preload
fmoclala
wang
resin
use
solidphas
chemistri
scheme
peptid
synthesi
perform
coupl
amino
acid
ester
hobt
use
dic
coupl
agent
excess
n
fmoc
amino
acid
ester
hobt
nmp
use
synthesi
ratio
amino
acid
dic
use
coupl
reaction
deprotect
n
fmoc
group
accomplish
treatment
piperidin
dmf
synthesi
complet
peptid
cleav
solid
support
deprotect
use
modifi
reagent
k
cocktail
consist
tfathioanisoleethanedithiolwaterphenol
cocktail
mixtur
filter
quick
snap
column
purifi
revers
phase
hplc
lyophil
afford
acetyl
group
compound
deprotect
treatment
mm
sodium
methoxid
methanol
product
purifi
biogel
fine
size
exclus
chromatographi
use
deioniz
water
solvent
lyophil
elut
afford
white
powder
next
challeng
conjug
alkyn
function
pam
cy
deriv
glycopeptid
azid
initi
effort
conjug
alkyn
azid
fragment
via
copper
catalyz
click
reaction
use
copper
sulfat
pentahydr
sodium
ascorb
fail
counteract
problem
use
cu
stabil
agent
tri
methyl
amin
tbta
known
increas
yield
copper
catalyz
click
reaction
significantli
stabil
situ
gener
cu
intermedi
conjug
eqv
eqv
presenc
copper
sulfat
pentahydr
eqv
tbta
eqv
sodium
ascorb
eqv
h
omeohthf
solvent
ambient
temperatur
afford
target
pam
conjug
h
compound
purifi
use
meohdichloromethan
solvent
elut
lyophil
afford
white
solid
prepar
liposom
use
dppc
liposom
formul
extrus
method
total
lipid
concentr
mm
test
specif
antibodi
bind
surfacedisplay
rha
glycosyl
epitop
prepar
three
batch
liposom
batch
posit
batch
liposom
formul
rhategcholesterol
pam
dppc
cholesterol
batch
lack
surfac
display
rha
epitop
formul
pam
dppc
cholesterol
batch
control
formul
dppc
cholesterol
particl
size
import
modul
immun
respons
neutral
liposom
therefor
homogen
stabil
well
size
character
liposom
evalu
scan
electron
microscop
sem
imag
figur
dynam
light
scatter
scatter
dl
measur
figur
support
inform
batch
liposom
found
stabl
day
around
nm
diamet
antibodi
bind
studi
show
posit
bind
batch
liposom
previous
gener
antirha
antibodi
well
mous
cd
antibodi
use
fitc
goat
antimous
igg
igm
secondari
antibodi
fluoresc
imag
coat
liposom
figur
bind
assay
prove
rha
epitop
conjug
display
surfac
liposom
antibodi
bind
antirha
antihuman
observ
batch
liposom
batch
liposom
demonstr
mous
antibodi
bind
shown
evalu
efficaci
vaccin
mous
model
gener
mice
antirha
antibodi
use
rhaficol
immun
naiv
anim
contain
signific
amount
antirha
antibodi
interest
immun
mice
rha
conjug
would
show
minim
tdepend
immun
respons
focus
attent
synthesi
rhaficol
conjug
sinc
carrier
ficol
report
excel
gener
tindepend
immun
respons
synthesi
rhaficol
conjug
scheme
tetraacetyl
rhamnopyranosid
glycosyl
ethanol
presenc
boron
trifluorid
ether
gener
peracetyl
rhamnos
glycosid
deacetyl
zemplen
condit
afford
rhamnos
glycosid
reduc
treatment
pdcharcoal
h
atmospher
furnish
rhamnos
glycosid
quantit
commerci
avail
ficol
oxid
sodium
period
acet
buffer
ph
follow
conjug
via
reduct
amin
use
sodium
cyanoborohydrid
borat
buffer
ph
produc
rhaficol
conjug
conjug
purifi
filtrat
dialysi
tube
molecular
weight
cut
valu
da
epitop
ratio
calcul
rhaficol
molecul
hydrolysi
follow
derivat
diethylamino
ethyl
benzamid
deaeab
comparison
uvhplc
peak
area
standard
curv
obtain
deaeab
deriv
method
describ
dalpathado
cowork
immunolog
result
discuss
first
goal
immunolog
studi
immun
mice
rhaficol
conjug
elicit
antirha
antibodi
titer
order
model
anim
could
simul
natur
occur
antirha
antibodi
found
human
serum
two
group
five
femal
balbc
mice
immun
day
rhaficollalum
adjuv
group
rhaovacomplet
freund
adjuv
cfa
group
b
mice
boost
three
time
day
either
rhaficollalum
group
rhaovaincomplet
freund
adjuv
icf
group
b
sera
collect
separ
group
b
rd
boost
antirha
antibodi
sera
two
group
mice
isotyp
screen
rhabsa
figur
support
inform
result
demonstr
antirha
antibodi
titer
rhaova
immun
mice
group
higher
rhaficol
immun
mice
howev
isotyp
distribut
confirm
rhaficol
rhaova
produc
antirha
antibodi
subclass
differ
proport
antirha
antibodi
rhaova
immun
domin
rhaficol
immun
produc
antibodi
compris
mainli
igm
act
similarli
stimul
high
affin
receptor
trigger
respons
macrophag
howev
also
stimul
low
affin
receptor
inhibit
signal
b
cell
receptor
therebi
diminish
bcell
activ
immunogen
macrophag
hand
antirha
antibodi
isotyp
rhaficol
immun
mice
serum
resembl
natur
occur
human
serum
presum
gener
tindepend
respons
thu
anticip
initi
immun
rhaficol
prior
vaccin
challeng
realist
anim
model
human
tcell
prolifer
assay
perform
determin
combin
antirha
antibodi
rhamodifi
liposom
vaccin
would
potenti
tcell
prolif
respons
first
part
studi
optim
prolifer
assay
condit
balbc
mice
immun
day
boost
day
emuls
adjuv
system
sa
peptid
per
mous
inject
mice
sacrif
day
spleen
remov
singl
cell
suspens
prepar
incub
alon
syngen
bone
marrow
dendrit
cell
dc
previous
puls
dose
antigen
observ
dc
enhanc
prolifer
figur
support
inform
previous
observ
mice
test
abil
antirha
antibodi
enhanc
antigen
present
spleen
cell
balbc
mice
immun
prepar
dc
balbc
bone
marrow
support
inform
puls
antigen
incub
pam
rha
liposom
antigen
concentr
togeth
antibodi
isol
either
rhaficol
rhaova
immun
mice
nonimmun
mice
puls
dc
ad
spleen
cell
prolifer
assess
day
spleen
tcell
prolifer
better
presenc
antirha
antibodi
rhaficol
rhaova
immun
mice
serum
presenc
control
serum
antibodi
antigen
concentr
rang
figur
also
tcell
prolifer
higher
presenc
antirha
antibodi
gener
rhaficol
count
per
minut
cpm
antigen
concentr
rhaova
cpm
antigen
concentr
even
though
titer
antirha
antibodi
higher
serum
rhaova
immun
mice
result
strongli
suggest
rhamodifi
antigen
effect
intern
present
apc
presenc
antirha
antibodi
particularli
lessinhibitori
isotyp
characterist
natur
antibodi
gener
rhaficol
immun
therefor
conclud
balbc
mice
antirha
antibodi
gener
rhaficol
immun
appropri
model
immunogen
rhaconjug
liposom
four
group
five
femal
balbc
mice
group
week
old
use
vaccin
studi
group
immun
day
boost
day
equivolum
emuls
rhaficol
prepar
pb
alum
adjuv
group
serv
control
group
depriv
rhaficollalum
immun
figur
mice
bled
day
elisa
perform
screen
sera
differ
group
rhabsa
show
antirha
antibodi
titer
group
higher
control
group
figur
thu
immun
rhaficol
confirm
gener
antirha
antibodi
experiment
group
mice
two
separ
liposom
formul
prepar
first
contain
dppc
cholesterol
pam
nmol
pam
liposom
second
contain
dppc
cholesterol
rhategcholesterol
pam
nmol
pam
rha
liposom
formul
total
lipid
concentr
mmol
vaccin
perform
day
group
given
subcutan
inject
pam
liposom
nmol
peptid
per
mous
group
given
subcutan
inject
pam
rha
liposom
nmol
peptid
per
mous
mice
boost
day
either
pam
liposom
group
nmol
peptid
per
mous
pam
rha
liposom
group
mice
bled
day
sera
evalu
antitn
antibodi
figur
antibodi
titer
determin
screen
sera
conjug
figur
data
show
group
similar
absorb
serum
dilut
prove
prior
immun
rhaficol
affect
respons
nonrha
conjug
vaccin
group
addit
rha
epitop
vaccin
alter
inher
immunogen
epitop
vaccin
group
titer
group
show
increas
compar
group
mediat
antirha
antibodydepend
antigenuptak
group
titer
approxim
titer
defin
highest
dilut
give
signal
background
antibodi
group
isotyp
figur
support
inform
show
group
show
increas
igm
isotyp
rel
group
specif
antibodi
toward
antigen
determin
competit
bind
experi
figur
serum
everi
group
dilut
incub
conjug
concentr
pb
prior
addit
elisa
plate
coat
conjug
absorb
decreas
uniformli
increas
concentr
free
serum
dilut
group
exampl
absorb
nm
serum
dilut
group
free
concentr
respect
result
confirm
specif
antibodi
toward
respect
antigen
antibodi
titer
gener
sole
taca
determin
screen
serum
dilut
everi
group
tnbsa
conjug
figur
also
observ
increas
antitn
antibodi
titer
group
comparison
group
attribut
better
uptak
antigen
presenc
antirha
antibodi
antibodydepend
antigenuptak
mechan
interest
find
studi
antibodi
titer
higher
correspond
antitn
antibodi
titer
serum
dilut
everi
group
assum
similar
level
antigen
plate
exampl
group
absorb
nm
antitn
measur
serum
dilut
respect
observ
demonstr
rhadisplay
vaccin
success
gener
antibodi
peptid
taca
abil
antibodi
vaccin
mice
serum
bind
human
tumor
cell
demonstr
human
leukemia
cell
cell
express
surfac
shown
bind
mous
antihuman
antibodi
cd
figur
serum
group
mice
also
recogn
tumor
cell
similar
effici
cd
antibodi
rel
nonimmun
mous
serum
figur
demonstr
antibodi
gener
glycopeptid
recogn
protein
nativ
environ
conclus
fulli
synthet
two
compon
vaccin
contain
lipopeptid
adjuv
pam
cy
append
acid
peptid
contain
taca
galnacothr
tn
synthes
success
formul
liposom
along
rha
cholesterol
conjug
result
liposom
homogen
size
stabl
two
day
bind
studi
antirha
mous
antihuman
antibodi
reveal
rha
glycopeptid
epitop
surfac
display
liposom
rhaficol
conjug
synthes
gener
antirha
antibodi
mice
vitro
prolifer
prime
mice
spleen
tcell
show
increas
prolifer
rhaliposom
presenc
antibodi
rhaficol
immun
mice
rel
nonimmun
mice
vaccin
studi
rhaand
nonrhadisplay
liposom
mice
either
nonimmun
immun
rhaficol
illustr
antitn
antibodi
higher
group
mice
previous
immun
rhaficol
later
vaccin
pam
rha
liposom
antibodi
serum
vaccin
mice
recogn
aberr
human
leukemia
cell
overal
vaccin
success
trigger
cell
humor
immun
enhanc
antirha
antibodi
depend
antigen
uptak
vaccin
use
separ
rhamnos
antigen
epitop
compon
vaccin
easili
target
differ
antigen
epitop
chang
peptid
without
chang
compon
refer
web
version
pubm
central
supplementari
materi
schemat
represent
interact
vivo
gener
immun
complex
lead
enhanc
antigen
uptak
apc
eg
dendrit
cell
fluoresc
microscop
imag
batch
liposom
magnif
imag
control
antibodi
antibodi
isol
preimmun
serum
st
nd
rd
imag
brightfield
fitc
overlay
b
imag
antirha
antibodi
st
nd
rd
imag
brightfield
fitc
overlay
c
imag
antimuc
antibodi
st
nd
rd
imag
brightfield
fitc
overlay
